Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Neuroendocrine Prostate Cancer
Related studies linked through entity extraction aliases.
Related studies linked through entity extraction aliases.